May 24 Market Morning Sentiment // $GALE Increasingly Positive

May 24, 2016 6:05 AM ETSLS, SPY
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2016

StockSocial™ is the leading Financial Influencer Network, industry experts and traders are able to give transparent, actionable insights. Our streaming chatter from your favorite social platforms filters out the noise and allows for an open forum to see what other investors are saying and gauge overall market sentiment.

Market Morning Sentiment - May 24th


With the prospect of a Fed interest rate hike in June, investors sold off some of their yield-play stocks on Monday and utilities fell 1%. The Treasury yield curve also began to flatten as anticipation of a rate hike grows. Market Sentiment on the S&P500 SPY ETF points to more 'risk aversion' behavior among traders, which is likely to continue until uncertainty around the Fed rate decision is quelled.

Influencer of the Day


$GALE Social Sentiment and Chatter Volume

Strong Buy: 73%

Galena Biopharma ($GALE) secures $23.4m in debt-financing, presents positive data

$GALE is a biopharmaceutical company that focuses on the development and commercialization of targeted oncology therapeutics that address unmet medical needs. $GALE aims to prevent cancer recurrence in survivors by harnessing the power of the immune system and has multiple mid-to-late stage clinical assets. Its lead product candidate NeuVax™(nelipepimut-S) recently recorded its 70th qualifying disease free survival event in its phase 3 PRESENT clinical trial. An interim safety and utility analysis of the trial is expected at the end of Q2. Check out $GALE 1Q16 financial results and corporate update here.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.